Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.

Saved in:

Bibliographic Details
Title:	Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.
Authors:	Dalm SU; Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands s.dalm@erasmusmc.nl., Sieuwerts AM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; and., Look MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; and., Melis M; Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Foekens JA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; and., de Jong M; Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; and.
Source:	Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2015 Oct; Vol. 56 (10), pp. 1487-93. Date of Electronic Publication: 2015 Aug 06.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1535-5667
DOI:	10.2967/jnumed.115.160739